(Reuters) – U.S. President Joe Biden said on Wednesday that 250,000 treatment courses of Pfizer’s newly authorized COVID-19 anti-viral drug will be available in January from the 10 million courses the United States had pre-purchased.
Biden said in a statement that his administration would work with states to ensure the treatments are distributed equitably and that hardest-hit communities are reached.
(Reporting by Paul Grant; Editing by Tim Ahmann)
Giants select Malik Nabers with 6th pick at 2024 NFL Draft
The NFL draft gives players a chance to flaunt their style on the red carpet
Suns’ Big 3 in a big pickle, down 2-0 against the Timberwolves as series moves to Phoenix
Roger Goodell envisions more overseas games, more streaming and more cities hosting the NFL draft
Eagles agree to three-year, $96 million extension with WR AJ Brown, AP source says
First with Trump, now with Kamala Harris: Kim Kardashian is advocating for criminal justice reform
USC’s move to cancel commencement amid protests draws criticism from students, alumni
Key moments from landmark Supreme Court arguments on Trump’s immunity claims
Google parent reports another quarter of robust growth, rolls out first-ever quarterly dividend
Microsoft quarterly profit rises 20% as tech giant pushes to get customers using AI products
17 states challenge federal rules entitling workers to accommodations for abortion
New York City to require warning labels for sugary foods and drinks in chain restaurants
Selling weight-loss and muscle-building supplements to minors in New York is now illegal
Minneapolis smokers to pay some of the highest cigarette prices in US with a $15 per-pack minimum
